# DDI Study of Single Oral Dose of Acoziborole With Sequential Co-administration of Midazolam and Dextromethorphan

> **NCT05947604** · PHASE1 · COMPLETED · sponsor: **Drugs for Neglected Diseases** · enrollment: 20 (actual)

## Conditions studied

- Trypanosomiasis, African

## Interventions

- **DRUG:** Acoziborole
- **DRUG:** Midazolam
- **DRUG:** Dextromethorphan

## Key facts

- **NCT ID:** NCT05947604
- **Lead sponsor:** Drugs for Neglected Diseases
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-09
- **Primary completion:** 2023-05-03
- **Final completion:** 2023-05-03
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2023-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05947604

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05947604, "DDI Study of Single Oral Dose of Acoziborole With Sequential Co-administration of Midazolam and Dextromethorphan". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05947604. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*